Final Rule Removes Samidorphan from CSA Control

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Final Rule Removes Samidorphan from CSA Control

Staff Writers

April 20, 2021 at 18:28:06 ET

A DEA rulemaking removing samidorphan (3-carboxamido-4-hydroxy naltrexone) from all Controlled Substances Act (CSA) schedules has been issued (86 Fed. Reg, 20284, Apr. 19, 2021). Samidorphan had been scheduled as a Schedule II controlled substance because it can be derived from opium alkaloids. The final rule has removed the regulatory controls and administrative, civil and crimin... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

Final Rule Removes Samidorphan from CSA Control

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT